What You Should Know:
- Perceptive Advisors and biotech accelerator Xontogeny, focused on seed investment, incubation and collaboration, have raised their second venture capital fund, the Perceptive Xontogeny Ventures Fund II (PXV Fund II), totaling an over-subscribed $515 million. This more than triples Assets Under Management to more than $700M in less than two years.
- The
Read More
Life Sciences | News, Analysis, Insights - HIT Consultant
Axtria Secures $150M for AI-Enabled Platform for Life Sciences
What You Should Know:
- Bain Capital Tech Opportunities has announced a $150 million growth investment in Axtria, a global cloud software and data analytics provider that helps life sciences businesses bring therapeutics to market faster – which will help Axtria to consolidate its strong position in cloud software and artificial intelligence by rapidly expanding its suite of life sciences-focused SaaS platforms.
- With the life sciences and healthcare
Read More
CVS Health Expands Return Ready Vaccine Clinics to Accommodate Small Business & Schools
What You Should Know:
- Today, CVS Health announced that it will expand Return Ready, the company’s comprehensive COVID-19 solution that helps employers and schools return and maintain healthy communities, with scalable vaccine clinics to accommodate smaller workplaces/communities and schools given the Food and Drug Administration (FDA) emergency use authorization of the Pfizer-BioNTech vaccine for adolescents ages 12 to 15.
- Small businesses and schools with more than
Read More
Florence Raises $80M to Expand Connectivity Platform for Clinical Trials
What You Should Know:
- Florence, a site connectivity platform in clinical trials, today announced the close of a $80 million Series C funding round led by Insight Partners, a global venture capital and private equity firm focused on investing in ScaleUp software companies. Existing investors Fulcrum Equity Partners, Bee Partners, and Flashpoint also joined this round.
- Based in Atlanta, GA, Florence is a global leader in remote connectivity and electronic document workflow management for
Read More
Cellares Secures $82M to Automate Cell Therapy Manufacturing
Cancer Centers: Here’s How We Can Restart Clinical Trials Today
Biopharmaceutical companies developing cancer treatments need to restart the clinical trials shut down or delayed during the early stages of the coronavirus pandemic. Some are holding back, however, due to a lack of confidence that sufficient eligible patients can be recruited and enrolled in the trials. Recruiting patients into a clinical trial was challenging before COVID-19 hit, and it has only become exponentially more difficult. Sponsors also know many patients have been putting off
Read More
Walgreens Rolls Out Mobile Clinics to Bring COVID-19 Vaccines to Underserved Communities in Chicago
What You Should Know:
- Walgreens will activate multiple mobile clinics in Chicago. The traveling mobile clinics will focus on bringing COVID-19 vaccines directly to underserved communities and those with barriers to accessing the vaccine. Over the next two months, additional mobile clinics will make stops in a number of locations across the country.
- Individuals will be able to walk up to a mobile clinic and receive a vaccination at that time from a Walgreens pharmacy team member.
Read More
DoD, Duke, John Hopkins, HJF, physIQ Launch 18-Month COVID-19 Clinical Trial Study
What You Should Know:
- Today, PhysIQ Inc. announced its partnership with Johns Hopkins University, Duke University and The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF), to support a clinical trial to evaluate products for early treatment and post-exposure treatment of COVID-19. The 18-month study will assess disease progression and provide early indication of infection. This DOD-funded initiative will assess the role of continuous biosensor
Read More
Phenomix Inks Licensing Deal with Mayo Clinic for Obesity Phenotype Blood Test
What You Should Know:
- Today, Phenomix Sciences announced the company has signed an exclusive technology licensing agreement with Mayo Clinic for a novel blood test that accurately predicts obesity phenotypes.
- The multi-level “omics” MyPhenome™ test leverages technology developed at Mayo Clinic to analyze genomics, metabolomics and hormone levels. Its AI-driven algorithmic solution identifies four specific obesity phenotypes to give doctors the ability to
Read More
CVS Health Launches Employer-Based COVID-19 Vaccination Program
What You Should Know:
Today, CVS Health announced it recently began administering COVID-19 vaccines at employer-based vaccination clinics through Return Ready, the company’s comprehensive COVID-19 solution that helps employers return and maintain healthy workforces.
- With vaccine hesitancy on the rise, federal and state governments are looking to partners, like employers and CVS Health, to help by making vaccines more convenient to access and enhancing public education
Read More
